Roth Capital analyst George Kelly lowered the firm’s price target on Xponential Fitness (XPOF) to $13 from $14 and keeps a Buy rating on the shares. One-time legal/lease expenses, elevated closures, and lagging development schedules obscured the resiliency of the company’s scaled brands, which are worth well in excess of the company’s current enterprise value, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XPOF:
